[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. https://doi.org/10.3322/caac.21492
|
[2]
|
Bergers, G. and Hanahan, D. (2008) Modes of Resistance to Anti-Angiogenic Therapy. Nature Reviews Cancer, 8, 592-603. https://doi.org/10.1038/nrc2442
|
[3]
|
Ellis, L.M. and Reardon, D.A. (2010) Is There Really a Yin and Yang to VEGF-Targeted Therapies? The Lancet Oncology, 11, 809-811. https://doi.org/10.1016/S1470-2045(10)70161-3
|
[4]
|
Meadows, K.L. and Hurwitz, H.I. (2012) Anti-VEGF Therapies in the Clinic. Cold Spring Harbor Perspectives in Medicine, 2, a006577. https://doi.org/10.1101/cshperspect.a006577
|
[5]
|
Jayson, G.C., Kerbel, R., Ellis, L.M. and Harris, A.L. (2016) Antiangiogenic Therapy in Oncology: Current Status and Future Directions. The Lancet, 388, 518-529. https://doi.org/10.1016/S0140-6736(15)01088-0
|
[6]
|
Mohamed, S.Y., Mohammed, H.L., Ibrahim, H.M., Mohamed, E.M. and Salah, M. (2019) Role of VEGF, CD105, and CD31 in the Prognosis of Colorectal Cancer Case. Journal of Gastrointestinal Cancer, 50, 23-34.
https://doi.org/10.1007/s12029-017-0014-y
|
[7]
|
Bhattacharya, R., Ye, X.C., Wang, R., Ling, X., McManus, M., Fan, F., Boulbes, D. and Ellis, L.M. (2016) Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells. Cancer Research, 76, 3014-3024. https://doi.org/10.1158/0008-5472.CAN-15-1605
|
[8]
|
Gerber, H.P., Dixit, V. and Ferrara, N. (1998) Vascular Endothelial Growth Factor Induces Expression of the Antiapoptotic Proteins Bcl-2 and A1 in Vascular Endothelial Cells. Journal of Biological Chemistry, 273, 13313-13316.
https://doi.org/10.1074/jbc.273.21.13313
|
[9]
|
Tomida, C., Nagano, H., Yamagishi, N., et al. (2017) Regorafenib Induces Adaptive Resistance of Colorectal Cancer Cells via Inhibition of Vascular Endothelial Growth Factor Receptor. The Journal of Medical Investigation, 64, 262-265. https://doi.org/10.2152/jmi.64.262
|
[10]
|
Appiah-Kubi, K., Wang, Y., Qian, H., Wu, M., Yao, X., Wu, Y. and Chen, Y. (2016) Platelet-Derived Growth Factor Receptor/Platelet-Derived Growth Factor (PDGFR/PDGF) System Is a Prognostic and Treatment Response Biomarker with Multifarious Therapeutic Targets in Cancers. Tumor Biology, 37, 10053-10066.
https://doi.org/10.1007/s13277-016-5069-z
|
[11]
|
Katoh, M. and Nakagama, H. (2014) FGF Receptors: Cancer Biology and Therapeutics. Medicinal Research Reviews, 34, 280-300. https://doi.org/10.1002/med.21288
|
[12]
|
Simon, T., Gagliano, T. and Giamas, G. (2017) Direct Effects of Anti-Angiogenic Therapies on Tumor Cells: VEGF Signaling. Trends in Molecular Medicine, 23, 282-292. https://doi.org/10.1016/j.molmed.2017.01.002
|
[13]
|
Friedman, J. (2014) 20 Years of Leptin: Leptin at 20: An Overview. Journal of Endocrinology, 223, T1-T8.
https://doi.org/10.1530/JOE-14-0405
|
[14]
|
Candelaria, P.V., Rampoldi, A., Harbuzariu, A., et al. (2017) Leptin Signaling and Cancer Chemoresistance: Perspectives. World Journal of Clinical Oncology, 8, 106-119. https://doi.org/10.5306/wjco.v8.i2.106
|
[15]
|
Sharma, D., Saxena, N.K., Vertino, P.M. and Anania, F.A. (2006) Leptin Promotes the Proliferative Response and Invasiveness in Human Endometrial Cancer Cells by Activating Multiple Signal-Transduction Pathways. Endocrine-Related Cancer, 13, 629-640. https://doi.org/10.1677/erc.1.01169
|
[16]
|
Choi, J.H., Park, S.H., Leung, P.C.K. and Choi, K.C. (2005) Expression of Leptin Receptors and Potential Effects of Leptin on the Cell Growth and Activation of Mitogen-Activated Protein Kinases in Ovarian Cancer Cells. The Journal of Clinical Endocrinology & Metabolism, 90, 207-210. https://doi.org/10.1677/erc.1.01169
|
[17]
|
Mantzoros, C.S., Magkos, F., Brinkoetter, M., Sienkiewicz, E., Dardeno, T.A., Kim, S.Y., et al. (2011) Leptin in Human Physiology and Pathophysiology. American Journal of Physiology-Endocrinology and Metabolism, 301, E567-E584. https://doi.org/10.1152/ajpendo.00315.2011
|
[18]
|
Booth, A., Magnuson, A., Fouts, J. and Foster, M. (2015) Adipose Tissue, Obesity and Adipokines: Role in Cancer Promotion. Hormone Molecular Biology and Clinical Investigation, 21, 57-74.
https://doi.org/10.1515/hmbci-2014-0037
|
[19]
|
Dauer, D.J., Ferraro, B., Song, L., Yu, B., Mora, L., Buettner, R., Enkemann, S., Jove, R. and Haura, E.B. (2005) Stat3 Regulates Genes Common to Both Wound Healing and Cancer. Oncogene, 24, 3397-3408.
https://doi.org/10.1038/sj.onc.1208469
|
[20]
|
Komiya, M., Fujii, G., Takahashi, M., Shimura, M., Noma, N., Shimizu, S., Onuma, W. and Mutoh, M. (2014) Bi-Directional Regulation between Adiponectin and Plasminogen Activator-Inhibitor-1 in 3T3-L1 Cells. In Vivo, 28, 13-19. http://iv.iiarjournals.org/content/28/1/13.full
|
[21]
|
Otani, K., Ishihara, S., Yamaguchi, H., et al. (2017) Adiponectin and Colorectal Cancer. Surgery Today, 47, 151-158.
https://doi.org/10.1007/s00595-016-1334-4
|
[22]
|
Spyrou, N., Avgerinos, K.I., Mantzoros, C.S. and Dalamaga, M. (2018) Classic and Novel Adipocytokines at the Intersection of Obesity and Cancer: Diagnostic and Therapeutic Strategies. Current Obesity Reports, 7, 260-275.
https://doi.org/10.1007/s13679-018-0318-7
|
[23]
|
Moon, H.S., Liu, X., Nagel, J.M., et al. (2013) Salutary Effects of Adiponectin on Colon Cancer: In Vivo and in Vitro Studies in Mice. Gut, 62, 561-570. https://doi.org/10.1136/gutjnl-2012-302092
|
[24]
|
Nigro, E., Schettino, P., Polito, R., et al. (2018) Adiponectin and Colon Cancer: Evidence for Inhibitory Effects on Viability and Migration of Human Colorectal Cell Lines. Molecular and Cellular Biochemistry, 448, 125-135.
https://doi.org/10.1007/s11010-018-3319-7
|
[25]
|
张群慧. 网膜素-1对结直肠癌干细胞增殖凋亡的影响及机制研究[D]: [硕士学位论文]. 合肥: 安徽医科大学, 2017.
|
[26]
|
Harvey, A.E., Lashinger, L.M. and Hursting, S.D. (2011) The Growing Challenge of Obesity and Cancer: An Inflammatory Issue. Annals of the New York Academy of Sciences, 1229, 45-52.
https://doi.org/10.1111/j.1749-6632.2011.06096.x
|
[27]
|
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L. and Karin, M. (2009) IL-6 and Stat3 are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer. Cancer Cell, 15, 103-113. https://doi.org/10.1016/j.ccr.2009.01.001
|
[28]
|
Beg, A.A. and Baltimore, D. (1996) An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death. Science, 274, 782-784. https://doi.org/10.1126/science.274.5288.782
|
[29]
|
Suman, S., Kallakury, B.V.S., Fornace Jr., A.J. and Datta, K. (2015) Protracted Upregulation of Leptin and IGF1 Is Associated with Activation of PI3K/Akt and JAK2 Pathway in Mouse Intestine after Ionizing Radiation Exposure. International Journal of Biological Sciences, 11, 274-283. https://doi.org/10.7150/ijbs.10684
|
[30]
|
Fazolini, N.P.B., Cruz, A.L.S., Werneck, M.B.F., Viola, J.P.B., Maya-Monteiro, C.M. and Bozza, P.T. (2015) Leptin Activation of mTOR Pathway in Intestinal Epithelial Cell Triggers Lipid Droplet Formation, Cytokine Production and Increased Cell Proliferation. Cell Cycle, 14, 2667-2676.
https://doi.org/10.1080/15384101.2015.1041684
|
[31]
|
Song, M.Y., Gong, J., Giovannucci, E.L., Berndt, S.I., Brenner, H., et al. (2015) Genetic Variants of Adiponectin and Risk of Colorectal Cancer. International Journal of Cancer, 137, 154-164. https://doi.org/10.1002/ijc.29360
|
[32]
|
Aleksandrova, K., di Giuseppe, R., Isermann, B., Biemann, R., Schulze, M., Wittenbecher, C., Fritsche, A., Lehmann, R., Menzel, J., Weikert, C., Pischon, T. and Boeing, H. (2016) Circulating Omentin as a Novel Biomarker for Colorectal Cancer Risk: Data from the EPIC-Potsdam Cohort Study. Cancer Research, 76, 3862-3871.
https://doi.org/10.1158/0008-5472.CAN-15-3464
|
[33]
|
Vivanco, I. and Sawyers, C.L. (2002) The Phosphatidylinositol 3-Kinase AKT Pathway in Human Cancer. Nature Reviews Cancer, 2, 489-501. https://doi.org/10.1038/nrc839
|
[34]
|
Fazeli, M.S., Dashti, H., Akbarzadeh, S., Assadi, M., Aminian, A., Keramati, M.R. and Nabipour, I. (2013) Circulating Levels of Novel Adipocytokines in Patients with Colorectal Cancer. Cytokine, 62, 81-85.
https://doi.org/10.1016/j.cyto.2013.02.012
|